# Pneumococcal Infectious Diseases FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/pneumococcal-infectious-diseases

> 4 upcoming FDA catalysts in pneumococcal Infectious Diseases: sinovac pcv13 lot 1 (SVA) on March 2027 (primary completion); sinovac pcv13 lot 1 (SVA) on Mar to Jun 2027 (topline data readout); sinovac pcv13 (SVA) on July 2027 (primary completion); sinovac pcv13 (SVA) on Jul to Oct 2027 (topline data readout).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| March 2027 | [Sinovac pcv13 lot 1 primary completion](https://sec-api.dev/pdufa/sinovac-pcv13-lot-1) | SVA | Pneumococcal Infectious Diseases | scheduled | "NCT07832500 (A Lot-to-Lot Consistency Clinical Trial of PCV13): Overall Status NOT_YET_RECRUITING; Phase PHASE3; Primary Completion 2027-03 (ESTIMATED); Lead Sponsor Sinovac Life Sciences Co., Ltd.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07832500)) |
| Mar to Jun 2027 | [Sinovac pcv13 lot 1 topline data readout](https://sec-api.dev/pdufa/sinovac-pcv13-lot-1) | SVA | Pneumococcal Infectious Diseases | scheduled | "NCT07832500 (A Lot-to-Lot Consistency Clinical Trial of PCV13): Overall Status NOT_YET_RECRUITING; Phase PHASE3; Primary Completion 2027-03 (ESTIMATED); Lead Sponsor Sinovac Life Sciences Co., Ltd.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07832500)) |
| July 2027 | [Sinovac pcv13 primary completion](https://sec-api.dev/pdufa/sinovac-pcv13) | SVA | Pneumococcal Infectious Diseases | scheduled | "NCT07593924 (Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)): Overall Status NOT_YET_RECRUITING; Phase PHASE3; Primary Completion 2027-07 (ESTIMATED); Lead Sponsor Sinovac Life Sciences Co., Ltd.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07593924)) |
| Jul to Oct 2027 | [Sinovac pcv13 topline data readout](https://sec-api.dev/pdufa/sinovac-pcv13) | SVA | Pneumococcal Infectious Diseases | scheduled | "NCT07593924 (Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)): Overall Status NOT_YET_RECRUITING; Phase PHASE3; Primary Completion 2027-07 (ESTIMATED); Lead Sponsor Sinovac Life Sciences Co., Ltd.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07593924)) |

## Drugs

- [Sinovac pcv13 lot 1](https://sec-api.dev/pdufa/sinovac-pcv13-lot-1) (SVA)
- [Sinovac pcv13](https://sec-api.dev/pdufa/sinovac-pcv13) (SVA)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/pneumococcal-infectious-diseases.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Pneumococcal Infectious Diseases FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/pneumococcal-infectious-diseases

```bibtex
@misc{secapidev_indications_pneumococcal_infectious_diseases_20261116,
  title        = {Pneumococcal Infectious Diseases FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/pneumococcal-infectious-diseases}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_pneumococcal_infectious_diseases_20261116","title":"Pneumococcal Infectious Diseases FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/pneumococcal-infectious-diseases","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
